Diana has over 20 years’ combined experience in protein biophysics and condensate science, assay development, drug discovery and scientific communications, across academia and biotech. Diana contributed to multiple seminal papers in the condensate field that (1) uncovered rules by which structural rearrangements within biomolecules influence the emergent properties of condensates and their function, (2) characterized the role of aberrant condensates across diseases, including ALS and cancers harboring fusion oncogenes, and (3) described the opportunities of targeting biomolecular condensates as a new generation of therapeutics.
At Dewpoint, Diana established and led the condensate biophysics group and contributed to project development, hypothesis generation, assay development and compound characterization efforts across the portfolio. Currently, Diana leads Dewpoint’s scientific and corporate communications efforts.
In her free time, Diana enjoys spending time with her family, hiking, traveling and escape rooms.
Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science